Cell survival pathways in A431 cells

Cell survival pathways in A431 cells refer to the complex intracellular signaling networks, primarily driven by the Epidermal Growth Factor Receptor (EGFR), that prevent apoptosis and promote growth in this specific human epidermoid carcinoma cell line [1]. A431 cells are widely utilized in pharmacology as a model system because they express exceptionally high levels of EGFR, making them highly sensitive to growth factor stimulation and receptor inhibition [2]. The primary survival signals are mediated through the PI3K/Akt and Ras/Raf/MEK/ERK pathways, which regulate gene expression and protein synthesis to maintain cellular homeostasis under stress [3]. Drugs targeting these pathways, such as tyrosine kinase inhibitors like Gefitinib and monoclonal antibodies like Cetuximab, aim to shut down these survival signals to induce tumor cell death [4]. However, "Cell survival pathways in A431 cells" is a descriptive term for a biological context rather than a specific molecular target like an enzyme or receptor. It encompasses multiple proteins and interactions, serving as a phenotypic readout for drug efficacy in oncology research [5]. Understanding these pathways is crucial for identifying mechanisms of drug resistance, such as the activation of alternative survival signals like the MET or HER3 pathways. Consequently, while not a target itself, this system is foundational for studying the therapeutic index of EGFR-targeted therapies.

Other names

A431 signaling cascadesEGFR-mediated survival signaling in A431A431 cell survival network

Inhibition of the Epidermal Growth Factor Receptor (EGFR) or downstream signaling components such as PI3K, Akt, or MEK to disrupt survival signaling and induce apoptosis or growth arrest.